Indicator Explainer
IgA
IgA is the immunoglobulin subclass that is associated with antibody-mediated mucosal immunity. It is secreted as dimers into the mucosa and is the most effective isotype at fixing complement by the alternative pathway, even though it lacks the ability to fix complement by the classical pathway. There are two subtypes in the human - IgA1 and IgA2.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C565. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-18. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — IgA (C565)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C565. NCI definition, reproduced without modification under CC BY 4.0.
- Detection of MOG-IgG and MOG-IgA in Maternal Breast Milk and Infant Blood in MOGAD: A Case Report. — Neurol Neuroimmunol Neuroinflamm, 2026-10-09 (PMID 42854177; literature)
- Follicle-associated epithelial tuft cells amplify type 2 mucosal immunity and IgA production. — Sci Immunol, 2026-10-09 (PMID 42853963; literature)
- Targeted-Release Formulation Budesonide (Nefecon) for the Treatment of IgA Nephropathy in Three Adolescents. — Kidney360, 2026-10-08 (PMID 42848663; literature)
- Clinical and pathological factors associated with eGFR slope in IgA nephropathy: a single-center retrospective cohort study. — Ren Fail, 2026-10-07 (PMID 42844235; literature)
